Advertisement

Cancer-Related Pelvic Pain

  • Sarah HwangEmail author
  • Megan Clark
Chapter

Abstract

Cancer-related pelvic pain is a disorder that can be difficult to evaluate and treat. The causes can be multifactorial, and treatment often requires a multidisciplinary approach. It is important to obtain a thorough history and physical to discover the cause or causes of the patient’s pain. Treatment may involve multiple physicians, physical therapists, and psychologists.

Keywords

Pelvic pain Dyspareunia Sexual dysfunction Levator spasm Pelvic cancers Abdominal pain Pelvic floor dysfunction 

References

  1. 1.
    Apte G, et al. Chronic female pelvic pain—part 1: clinical pathoanatomy and examination of the pelvic region. Pain Pract. 2012;12(2):88–110.CrossRefGoogle Scholar
  2. 2.
    Stein SL. Chronic pelvic pain. Gastroenterol Clin N Am. 2013;42(4):785–800.CrossRefGoogle Scholar
  3. 3.
    Reiter R. Evidence-based management of chronic pelvic pain. Clin Obstet Gynecol. 1998;41(2):422–35.CrossRefGoogle Scholar
  4. 4.
    Tu FF, As-Sanie S, Steege JF. Musculoskeletal causes of chronic pelvic pain: a systematic review of diagnosis: part I. Obstet Gynecol Surv. 2005;60(6):379–85.CrossRefGoogle Scholar
  5. 5.
    Mathias SD, et al. Chronic pelvic pain: prevalence, health-related quality of life, and economic correlates. Obstet Gynecol. 1996;87(3):321–7.CrossRefGoogle Scholar
  6. 6.
    Howlader N, et al. SEER cancer statistics review, 1975–2012. Bethesda: National Cancer Institute; 2015.Google Scholar
  7. 7.
    Prather H, et al. Review of anatomy, evaluation, and treatment of musculoskeletal pelvic floor pain in women. PM R. 2009;1(4):346–58.CrossRefGoogle Scholar
  8. 8.
    Barber MD, et al. Innervation of the female levator ani muscles. Am J Obstet Gynecol. 2002;187(1):64–71.CrossRefGoogle Scholar
  9. 9.
    Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65(1):5–29.CrossRefGoogle Scholar
  10. 10.
    Huffman LB, et al. Maintaining sexual health throughout gynecologic cancer survivorship: a comprehensive review and clinical guide. Gynecol Oncol. 2016;140(2):359–68.CrossRefGoogle Scholar
  11. 11.
    Boggess JF, et al. A comparative study of 3 surgical methods for hysterectomy with staging for endometrial cancer: robotic assistance, laparoscopy, laparotomy. Am J Obstet Gynecol. 2008;199(4):360 e1–9.CrossRefGoogle Scholar
  12. 12.
    L Aerts PE, J Verhaeghe W, Poppe I, Vergote FA. Sexual functioning in women after surgical treatment for endometrial cancer: a prospective controlled study. J Sex Med. 2015;12(1):198–209.CrossRefGoogle Scholar
  13. 13.
    Katz A, et al. Early development of vaginal shortening during radiation therapy for endometrial or cervical cancer. Int J Gynecol Cancer. 2001;11(3):234–5.CrossRefGoogle Scholar
  14. 14.
    Brand AH, Bull CA, Cakir B. Vaginal stenosis in patients treated with radiotherapy for carcinoma of the cervix. Int J Gynecol Cancer. 2006;16(1):288–93.CrossRefGoogle Scholar
  15. 15.
    Jemal A, et al. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90.CrossRefGoogle Scholar
  16. 16.
    Jackson KS, Naik R. Pelvic floor dysfunction and radical hysterectomy. Int J Gynecol Cancer. 2006;16:354–63.CrossRefGoogle Scholar
  17. 17.
    Park SY, et al. Quality of life and sexual problems in disease-free survivors of cervical cancer compared with the general population. Cancer. 2007;110(12):2716–25.CrossRefGoogle Scholar
  18. 18.
    Greimel ER, et al. Quality of life and sexual functioning after cervical cancer treatment: a long-term follow-up study. Psychooncology. 2009;18(5):476–82.CrossRefGoogle Scholar
  19. 19.
    Pieterse QD, et al. An observational longitudinal study to evaluate miction, defecation, and sexual function after radical hysterectomy with pelvic lymphadenectomy for early-stage cervical cancer. Int J Gynecol Cancer. 2006;16(3):1119–29.CrossRefGoogle Scholar
  20. 20.
    Collaboration, C.f.C.C.M.-A. Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials. J Clin Oncol. 2008;26(35):5802–12.CrossRefGoogle Scholar
  21. 21.
    Green JA, et al. Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix (review). Cochrane Database Syst Rev. 2005;3:CD002225.Google Scholar
  22. 22.
    Kirwan JM, et al. A systematic review of acute and late toxicity of concomitant chemoradiation for cervical cancer. Radiother Oncol. 2003;68:217–26.CrossRefGoogle Scholar
  23. 23.
    Bruner DW, et al. Measurement of vaginal length: reliability of the vaginal sound—a gynecologic oncology group study. Int J Gynecol Cancer. 2006;16(5):1749–55.CrossRefGoogle Scholar
  24. 24.
    Noronha AF, et al. Treatments for invasive carcinoma of the cervix: what are their impacts on the pelvic floor functions? Int Braz J Urol. 2013;39(1):46–54.CrossRefGoogle Scholar
  25. 25.
    Buković D, et al. Sexual functioning and body image of patients treated for ovarian Cancer. Sex Disabil. 2008;26(2):63–73.CrossRefGoogle Scholar
  26. 26.
    Hindocha A, Beere L, Dias S, Watson A, Ahmad G. Adhesion prevention agents for gynaecological surgery: an overview of Cochrane reviews. Cochrane Database Syst Rev. 2015. CD 011254.Google Scholar
  27. 27.
    Hampl M, et al. New aspects of vulvar cancer: changes in localization and age of onset. Gynecol Oncol. 2008;109(3):340–5.CrossRefGoogle Scholar
  28. 28.
    Stehman FB, Look KY. Carcinoma of the vulva. Obstet Gynecol. 2006;107(3):719–33.CrossRefGoogle Scholar
  29. 29.
    Gaarenstroom KN, et al. Postoperative complications after vulvectomy and inguinofemoral lymphadenectomy using separate groin incisions. Int J Gynecol Cancer. 2003;13(4):522–7.CrossRefGoogle Scholar
  30. 30.
    Barlow EL, et al. Sexuality and body image following treatment for early-stage vulvar cancer: a qualitative study. J Adv Nurs. 2014;70(8):1856–66.CrossRefGoogle Scholar
  31. 31.
    Albertsen PC, Hanley JA, Fine J. 20-year outcomes following conservative management of clinically localized prostate cancer. JAMA. 2005;293(17):2095–101.CrossRefGoogle Scholar
  32. 32.
    Lu-Yao GL, et al. Outcomes of localized prostate cancer following conservative management. JAMA. 2009;302(11):1202–9.CrossRefGoogle Scholar
  33. 33.
    Thor M, et al. Radiation dose to the penile structures and patient-reported sexual dysfunction in long-term prostate cancer survivors. J Sex Med. 2015;12(12):2388–97.CrossRefGoogle Scholar
  34. 34.
    Budaus L, et al. Functional outcomes and complications following radiation therapy for prostate cancer: a critical analysis of the literature. Eur Urol. 2012;61:112–27.CrossRefGoogle Scholar
  35. 35.
    Potosky AL, et al. Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study. J Natl Cancer Inst. 2004;96(18):1358–67.CrossRefGoogle Scholar
  36. 36.
    Carter J, Goldfrank D, Schover LR. Simple strategies for vaginal health promotion in cancer survivors. J Sex Med. 2011;8(2):549–59.CrossRefGoogle Scholar
  37. 37.
    Stones RW, Mountfield J. Interventions for treating chronic pelvic pain in women. Cochrane Database Syst Rev. 2000. CD000387.Google Scholar
  38. 38.
    Johnson N, Miles TP, Cornes P. Dilating the vagina to prevent damage from radiotherapy: systematic review of the literature. BJOG. 2010;117(5):522–31.CrossRefGoogle Scholar
  39. 39.
    Bygdeman M, Swahn ML. Replens versus Dienoestrol cream in the symptomatic treatment of vaginal atrophy in postmenopausal women. Maturitas. 1996;23(3):259–63.CrossRefGoogle Scholar
  40. 40.
    Chen J, et al. Evaluation of the efficacy and safety of hyaluronic acid vaginal gel to ease vaginal dryness: a multicenter, randomized, controlled, open-label, parallel-group, clinical trial. J Sex Med. 2013;10(6):1575–84.CrossRefGoogle Scholar
  41. 41.
    Suckling JA, et al. Local estrogen for vaginal atrophy in postmenopausal women. Cochrane Database Syst Rev. 2006. CD001500.Google Scholar
  42. 42.
    Writing Group for the Women’s Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women principal results from the women’s health initiative randomized controlled trial. JAMA. 2002;288(3):321–33.CrossRefGoogle Scholar
  43. 43.
    Lee RB, Burke TW, Park RC. Estrogen replacement therapy following treatment for stage I endometrial carcinoma. Gynecol Oncol. 1990;36:189–91.CrossRefGoogle Scholar
  44. 44.
    Barakat RR, et al. Randomized double-blind trial of estrogen replacement therapy versus placebo in stage I or II endometrial cancer: a gynecologic oncology group study. J Clin Oncol. 2006;24(4):587–92.CrossRefGoogle Scholar
  45. 45.
    Goetsch MF, Lim JYC, B A. A practical solution for dyspareunia in breast cancer survivors: a randomized controlled trial. J Clin Oncol. 2015;33(30):3394–400.CrossRefGoogle Scholar
  46. 46.
    Goldfinger C, et al. A prospective study of pelvic floor physical therapy: pain and psychosexual outcomes in provoked vestibulodynia. J Sex Med. 2009;6(7):1955–68.CrossRefGoogle Scholar
  47. 47.
    Portenoy RK. Cancer pain. Epidemiology and syndromes. Cancer. 1989;63(11 Suppl):2298–307.CrossRefGoogle Scholar
  48. 48.
    Schug SA, Zech D, Dorr U. Cancer pain management according to WHO analgesic guidelines. J Pain Symptom Manage. 1990;5(1):27–32.CrossRefGoogle Scholar
  49. 49.
    Caraceni A, Portenoy RK. Pain management in patients with pancreatic carcinoma. Cancer. 1996;78(3 Suppl):639–53.CrossRefGoogle Scholar
  50. 50.
    Carrico DJ, Peters KM. Vaginal diazepam use with urogenital pain/pelvic floor dysfunction: serum diazepam levels and efficacy data. Urol Nurs. 2011;31(5):279–84. 299CrossRefGoogle Scholar
  51. 51.
    Malec-Milewska M, et al. Neurolytic block of ganglion of Walther for the management of chronic pelvic pain. Wideochir Inne Tech Maloinwazyjne. 2014;9(3):458–62.PubMedPubMedCentralGoogle Scholar
  52. 52.
    de Leon-Casasola OA. Critical evaluation of chemical neurolysis of the sympathetic axis for cancer pain. Cancer Control. 2000;7(2):142–8.CrossRefGoogle Scholar
  53. 53.
    Michalek P, Dutka J. Computed tomography-guided anterior approach to the superior hypogastric plexus for noncancer pelvic pain: a report of two cases. Clin J Pain. 2005;21(6):553–6.CrossRefGoogle Scholar
  54. 54.
    Ghoneim AA, Mansour SM. Comparative study between computed tomography guided superior hypogastric plexus block and the classic posterior approach: a prospective randomized study. Saudi J Anaesth. 2014;8(3):378–83.CrossRefGoogle Scholar
  55. 55.
    Mishra S, Bhatnagar S, Rana SP, Khurana D, Thulkar S. Efficacy of the anterior ultrasound-guided superior hypogastric plexus neurolysis in pelvic cancer pain in advanced gynecological cancer patients. Pain Med. 2013;14:837–42.CrossRefGoogle Scholar
  56. 56.
    Moldwin RM, Fariello JY. Myofascial trigger points of the pelvic floor: associations with urological pain syndromes and treatment strategies including injection therapy. Curr Urol Rep. 2013;14(5):409–17.CrossRefGoogle Scholar
  57. 57.
    Abbott JA, et al. Botulinum toxin type a for chronic pain and pelvic floor spasm in women: a randomized controlled trial. Obstet Gynecol. 2006;108(4):915–23.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Shirley Ryan AbilityLabChicagoUSA
  2. 2.University of Kansas, Department of Physical Medicine and RehabilitationKansas CityUSA

Personalised recommendations